Several cancers underrepresented in clinical trials
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
Several cancers with a high burden of disease are not receiving the clinical trial investment they require. Four of the five cancers that result in the greatest burden of disease have
relatively few clinical trials: lung, colorectal, prostate and pancreatic cancers.
The University of Sydney researchers found of 386 interventional cancer trials open to recruitment in Australia, breast cancer accounted for 62 trials. Yet only 24 trials were being
conducted on lung cancer, despite it being responsible for the greatest burden of disease.